Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Siga Technologies

Clinical trials sponsored by Siga Technologies, explained in plain language.

SIGA Technologies SIGA NASDAQ

Develops pharmaceuticals for viral infections, including smallpox treatment TPOXX.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

Does a smallpox drug weaken the vaccine? new study aims to find out.

Knowledge-focused Ongoing

This study looks at whether taking the smallpox drug TPOXX changes how well the JYNNEOS vaccine works. About 100 healthy adults aged 18 to 42 will get two doses of the vaccine and either TPOXX or a placebo for 28 days. Researchers will check for side effects and measure immune re…

Phase: PHASE2 • Sponsor: SIGA Technologies • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:03 UTC